Torreya Partners is headquartered in New York, New York.
Torreya Partners was founded in 2007.
Torreya Partners offers Capital Raising, Fairness Opinions, Financial Restructuring and M&A Advisory.
555 Madison Avenue Suite 1201,
New York, New York 10022
United States
(212) 257-5801
www.torreyapartners.com
Torreya Partners is a boutique advisory firm focused on providing strategic advice and assistance to clients in the life science sector. The Firm's practice areas include mergers and acquisitions advisory, divestitures, financial restructuring, and fairness opinions. Torreya Partners was formed in 2007 and is based in New York, New York. In 2022, Torreya Partners was acquired by Stifel.
| Year | ≤ '18 | '19 | '20 | '21 | '22 | '23 | T |
|---|---|---|---|---|---|---|---|
| Buyside (0.2/yr) | 4 | - | - | - | - | 1 | 5 |
| Sellside (1.0/yr) | 15 | 1 | - | 2 | 2 | - | 20 |
| 25 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2023-02-23 | - | Life Science |
| Sign-up to View | 2022-08-24 | - | Life Science |
| Sign-up to View | 2022-01-11 | - | Life Science |
| Sign-up to View | 2021-05-05 | - | Life Science |
| Sign-up to View | 2021-03-31 | - | Medical Products |
| Sign-up to View | 2019-04-04 | - | Life Science |
| Sign-up to View | 2018-03-28 | 61M USD | Life Science |
| Sign-up to View | 2017-10-30 | - | Life Science |
| Sign-up to View | 2017-07-31 | 33M USD | Life Science |
| Sign-up to View | 2017-04-20 | 1.1B USD | Life Science |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Life Science | Sign-up to View | ||
| Medical Products | Sign-up to View | ||
| Healthcare Services | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United States | Sign-up to View | ||
| California | Sign-up to View | ||
| Massachusetts | Sign-up to View | ||
| New York | Sign-up to View | ||
| Pennsylvania | Sign-up to View | ||
| Minnesota | Sign-up to View | ||
| North Carolina | Sign-up to View | ||
| India | Sign-up to View | ||
| United Kingdom | Sign-up to View | ||
| Australia | Sign-up to View | ||
| Switzerland | Sign-up to View | ||
| Canada | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Merger | Sign-up to View | ||
| Divestiture | Sign-up to View | ||
| Growth Capital | Sign-up to View | ||
| Going Private | Sign-up to View | ||
| Stake Purchase | Sign-up to View | ||
| Total | Sign-up to View | ||
| PE Firms (1) | Deals |
|---|---|
|
Sign-up to View |
1 |
| Corporate (25) | Deals |
|---|---|
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Upsher-Smith Laboratories, Inc. - Generics Business $1.1B (2017-04-20) |
|
